Targeting β-cell mass in type 2 diabetes: Promise and limitations of new drugs based on incretins

Marzieh Salehi, Benedikt A. Aulinger, David A. D'Alessio

Research output: Contribution to journalReview article

80 Scopus citations

Fingerprint Dive into the research topics of 'Targeting β-cell mass in type 2 diabetes: Promise and limitations of new drugs based on incretins'. Together they form a unique fingerprint.

Medicine & Life Sciences